Point72 Hong Kong’s Aerie Pharmaceuticals AERI Stock Holding History

Point72 Hong Kong’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-948	Closed	-$17K	–	2481
2021 Q1	$17K	Buy	948 +45	+5%	+$777	﹤0.01%	1514
2020 Q4	$12K	Sell	903 -932	-51%	-$11.3K	﹤0.01%	1520
2020 Q3	$22K	Sell	1,835 -1,597	-47%	-$19.5K	﹤0.01%	855
2020 Q2	$51K	Buy	+3,432	New	+$50.8K	0.01%	736
2020 Q1	–	Sell	-260	Closed	-$6K	–	1480
2019 Q4	$6K	Buy	+260	New	+$5.38K	﹤0.01%	1034
2019 Q3	–	Sell	-30	Closed	-$1K	–	1453
2019 Q2	$1K	Buy	+30	New	+$1.16K	﹤0.01%	1074
2018 Q3	–	Sell	-17	Closed	-$1K	–	1273
2018 Q2	$1K	Buy	+17	New	+$951	﹤0.01%	850
2017 Q4	–	Sell	-230	Closed	-$11K	–	1159
2017 Q3	$11K	Buy	+230	New	+$12.5K	0.01%	481
2017 Q2	–	Sell	-498	Closed	-$23K	–	1085
2017 Q1	$23K	Buy	+498	New	+$22.2K	0.03%	383

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Point72 Hong Kong's AERI Position: Q2 2021 in Review

Point72 Hong Kong sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 948 shares — an estimated $17K sold.

Point72 Hong Kong first reported a position in AERI in Q1 2017 and held it in 9 quarters. The position peaked at $51K in Q2 2020. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

Point72 Hong Kong reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Point72 Hong Kong sold 948 Aerie Pharmaceuticals shares in Q2 2021, an estimated $17K.
Point72 Hong Kong first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 9 quarters.
Point72 Hong Kong's Aerie Pharmaceuticals position peaked at $51K in Q2 2020.
142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.